All Stories

  1. FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist

    Article • Scandinavian Journal of Urology, January 2019, Taylor & Francis

    Professor Bertrand Tombal, Francesco Boccardo, neal shore

  2. Darolutamide (ODM-201) for the treatment of prostate cancer

    Article • Expert Opinion on Pharmacotherapy, May 2017, Taylor & Francis

    neal shore

  3. Advances in the understanding of cancer immunotherapy

    Article • BJU International, May 2015, Wiley

    neal shore

  4. Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence

    Article • Research and Reports in Urology, October 2012, Taylor & Francis

    neal shore